DE69503760T2 - Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament - Google Patents

Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament

Info

Publication number
DE69503760T2
DE69503760T2 DE69503760T DE69503760T DE69503760T2 DE 69503760 T2 DE69503760 T2 DE 69503760T2 DE 69503760 T DE69503760 T DE 69503760T DE 69503760 T DE69503760 T DE 69503760T DE 69503760 T2 DE69503760 T2 DE 69503760T2
Authority
DE
Germany
Prior art keywords
compound
same
potassium salt
medicine containing
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69503760T
Other languages
English (en)
Other versions
DE69503760D1 (de
Inventor
Terukage Wakunaga Seiya Hirata
Nobuya Wakunaga Seiyaku Sakae
Koichi Wakunaga Seiyaku Tamura
Masayasu Wakunaga Seiy Okuhira
Hirotaka Wakunaga Seiyak Amano
Masaharu Wakunaga Sei Yokomoto
Jun Wakunaga Seiyaku Nomiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69503760D1 publication Critical patent/DE69503760D1/de
Publication of DE69503760T2 publication Critical patent/DE69503760T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69503760T 1994-02-10 1995-02-08 Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament Expired - Fee Related DE69503760T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1622094 1994-02-10
JP12873994 1994-06-10
PCT/JP1995/000174 WO1995021837A1 (fr) 1994-02-10 1995-02-08 Sel de potassium de derive biphenylmethane et medicament le contenant

Publications (2)

Publication Number Publication Date
DE69503760D1 DE69503760D1 (de) 1998-09-03
DE69503760T2 true DE69503760T2 (de) 1998-12-17

Family

ID=26352497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69503760T Expired - Fee Related DE69503760T2 (de) 1994-02-10 1995-02-08 Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament

Country Status (10)

Country Link
EP (1) EP0744402B1 (de)
KR (1) KR970700672A (de)
CN (1) CN1140450A (de)
AT (1) ATE169014T1 (de)
CA (1) CA2181260A1 (de)
DE (1) DE69503760T2 (de)
DK (1) DK0744402T3 (de)
ES (1) ES2120180T3 (de)
GR (1) GR3027777T3 (de)
WO (1) WO1995021837A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69507887T2 (de) * 1994-09-20 1999-06-17 Wakunaga Seiyaku Kk Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
KR19990022836A (ko) * 1995-06-27 1999-03-25 기스케 와구나가, 구사이 요시히로 테트라졸릴화 비페닐메탄 유도체의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017681A1 (en) * 1992-03-02 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
KR950702544A (ko) * 1992-08-11 1995-07-29 구사이 요시히로 비페닐메탄 유도체 및 이를 함유하는 약제
DE69507887T2 (de) * 1994-09-20 1999-06-17 Wakunaga Seiyaku Kk Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen

Also Published As

Publication number Publication date
AU1591295A (en) 1995-08-29
ES2120180T3 (es) 1998-10-16
CN1140450A (zh) 1997-01-15
EP0744402A1 (de) 1996-11-27
KR970700672A (ko) 1997-02-12
EP0744402A4 (de) 1997-03-26
AU685586B2 (en) 1998-01-22
EP0744402B1 (de) 1998-07-29
GR3027777T3 (en) 1998-11-30
WO1995021837A1 (fr) 1995-08-17
DK0744402T3 (da) 1999-05-03
CA2181260A1 (en) 1995-08-17
ATE169014T1 (de) 1998-08-15
DE69503760D1 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
DE122006000051I1 (de) Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
MA28011A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents therapeutiques
TNSN05165A1 (fr) Derives de pyrrolopyrimidine
ATE164080T1 (de) Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
ATE210118T1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
DE69503760D1 (de) Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69121551T2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE69328585D1 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
FR2845087B1 (fr) Nouveaux acides arylhexadienoiques substitues et leurs esters,utilisables dans le traitement et la prevention du diabete, des dyslipidemies,de l'atherosclerose, compositions pharmaceutiques les contenant et procedes de preparation
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
TH16370A (th) สารประกอบไดแอริล
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
RU96118094A (ru) Калиевая соль производного бифенилметана и содержащие их фармацевтические препараты

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee